지노믹트리 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 오태정, was filed 22 May 2026.
지노믹트리: what insiders have been doing
This page follows insider dealings at 지노믹트리 as filed with DART (FSS), a company from the Health Care sector. From 1 November 2025 to 1 November 2026, the disclosure feed for 지노믹트리 logged 9 filings by 5 insiders.
Not one open-market sale was filed. On the buying side, 4 insiders reported 8 purchases. No amount is published for 8 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 3 senior executives and 1 board member.
The last insider purchase was made public on 22 May 2026, 172 days ago.
With 9 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. The full history, which starts in 2022, counts 19 purchases against 6 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,000 sharesShareKRXDART:20260522000581Canonical exit: 20 Aug 2026 (T+90)
- 1,000 sharesShareKRXDART:20260522000584Canonical exit: 20 Aug 2026 (T+90)
- 2,000 sharesShareKRXDART:20260522000572Canonical exit: 20 Aug 2026 (T+90)
- 2,000 sharesShareKRXDART:20260522000624Canonical exit: 20 Aug 2026 (T+90)
- ●Executives0DART
- 3,500 sharesShareKRXDART:20260112000398Canonical exit: 12 Apr 2026 (T+90)
- 1,750 sharesShareKRXDART:20260112000389Canonical exit: 12 Apr 2026 (T+90)
- 3,500 sharesShareKRXDART:20260112000403Canonical exit: 12 Apr 2026 (T+90)
- 3,500 sharesShareKRXDART:20260112000393Canonical exit: 12 Apr 2026 (T+90)
- ●Executives0DART
- ShareKRXDART:20240705000446Canonical exit: 1 Oct 2024 (T+90)
- ShareKRXDART:20240705000440Canonical exit: 1 Oct 2024 (T+90)
- ●Executives0DART
- 1,232 sharesKRXDART:20231030000413
- ShareKRXDART:20231020000428Canonical exit: 15 Jan 2024 (T+90)
- 830,071 sharesKRXDART:20230825000686
- 30,249 sharesKRXDART:20230824000424Canonical exit: 7 Nov 2023 (T+90)
- 348,328 sharesKRXDART:20230810000688
- 584,105 sharesKRXDART:20230710000522
- ShareKRXDART:20230524000049Canonical exit: 17 Aug 2023 (T+90)
- ShareKRXDART:20230524000036Canonical exit: 17 Aug 2023 (T+90)
- ShareKRXDART:20230524000038Canonical exit: 17 Aug 2023 (T+90)
- ShareKRXDART:20230524000054Canonical exit: 17 Aug 2023 (T+90)
- ShareKRXDART:20230524000045Canonical exit: 17 Aug 2023 (T+90)
- 54,500 sharesKRXDART:20230503000736
25 of 28 declarations
About 지노믹트리
Genomictree is a leader in genetic testing in South Korea, providing innovative solutions for the diagnosis and treatment of diseases. The company is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
